Cheryl Scott sold $196k of PGNY
director at Progyny, Inc.. 7,439 shares at an average of $26.39, traded Jun 1, 2026, filed Jun 3, 2026.
Score components
- +15RoleDirector
- +12Trade size$196k at market
- +10Share of holdings soldSold 27% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001551306-26-000118, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | MOption exercise Common Stock | +14,667 | $13.00 | $191k | 34,439 | Jun 3, 2026 |
| Jun 1, 2026 | FTax withholding Common Stock | -7,228 | $26.38 | $191k | 27,211 | Jun 3, 2026 |
| Jun 1, 2026 | SOpen-market sale Common Stock | -7,439 | $26.39 | $196k | 19,772 | Jun 3, 2026 |
| Jun 1, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -14,667 | $0.00 | $0 | 29,333 | Jun 3, 2026 |
Related signals
Other insiders at Progyny, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | Progyny, Inc. | Allison Swartz EVP, GC | $102k 3,903 shares | -5% | |
| 42Moderate | Progyny, Inc. | Kevin K Gordon director | $312k 11,500 shares | -63% | |
| 42Moderate | Progyny, Inc. | Kevin K Gordon director | $321k 11,500 shares | -63% | |
| 8Weak | Progyny, Inc. | Melissa B Cummings Chief Operating Officer | $71k 2,244 shares | -3% | |
| 25Weak | Progyny, Inc. | Mark S. Livingston CHIEF FINANCIAL OFFICER | $64k 2,517 shares | -3% | |
| 16Weak | Progyny, Inc. | Allison Swartz EVP, GC | $45k 1,798 shares | -2% | |
| 21Weak | Progyny, Inc. | Geoffrey Clapp Chief Product Officer | $39k 1,530 shares | -3% | |
| 17Weak | Progyny, Inc. | Mark S. Livingston CHIEF FINANCIAL OFFICER | $7,310 279 shares | -0% | |
| 17Weak | Progyny, Inc. | Allison Swartz EVP, GC | $61k 2,398 shares | -3% | |
| 51Moderate | Progyny, Inc. | Kevin K Gordon director | $137k 5,500 shares | -37% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.